OncoCyte Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 33
Employees
  • Stock Symbol
  • OCX
Stock Symbol
  • Investments
  • 4
  • Share Price
  • $4.88
  • (As of Monday Closing)

OncoCyte General Information

Description

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, the company also developing screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through United States and it earns revenue from the sale of diagnostic tests.

Contact Information

Ownership Status
Publicly Held
Financing Status
Pending Transaction (M&A)
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Stock Exchange
ASE
Primary Office
  • 15 Cushing
  • Irvine, CA 92618
  • United States
+1 (949) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoCyte Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.88 $4.92 $1.15 - $6.57 $436M 88.6M 2.49M -$0.51

OncoCyte Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 83,932 109,684 46,500 136,710
Revenue 713 0 0 0
EBITDA (30,894) (22,374) (14,979) (18,578)
Net Income (31,577) (22,426) (15,754) (19,375)
Total Assets 57,776 39,859 9,518 10,216
Total Debt 8,450 5,936 1,719 2,497
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OncoCyte Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OncoCyte‘s full profile, request access.

Request a free trial

OncoCyte Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnos
Diagnostic Equipment
Irvine, CA
33 As of 2019
000.00
000000000 000.00

00000000

r in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint oc
0000000000000
Singapore, Singapore
00 As of 0000
000.00
000000000 000.00

00000000

, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
0000000000 000000000
Redwood City, CA
000 As of 0000
00000
0.000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoCyte Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VolitionRx Corporate Backed or Acquired Singapore, Singapore 00 000.00 000000000 000.00
00000000 000000 Formerly VC-backed Redwood City, CA 000 00000 00000000 00000
00000000 Formerly VC-backed San Diego, CA 00 0000 000000000 0000
00000000 Formerly VC-backed Boulder, CO 000 00000 00000000 00000
00000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
You’re viewing 5 of 40 competitors. Get the full list »

OncoCyte Executive Team (8)

Name Title Board Seat Contact Info
Ronald Andrews Chief Executive Officer & Board Member
William Annett Chief Executive Officer & Board Member
Mitchell Levine Chief Financial Officer, Finance
Albert Parker JD Chief Operating Officer, Operations & Secretary, Administration
Lyndal Hesterberg Ph.D Chief Scientific Officer
You’re viewing 5 of 8 executive team members. Get the full list »

OncoCyte Board Members (10)

Name Representing Role Since
Andrew Last Ph.D Self Board Member 000 0000
Cavan Redmond OncoCyte Chairman & Board Member 000 0000
Jennifer Carter MD Self Board Member 000 0000
Ronald Andrews OncoCyte Chief Executive Officer & Board Member 000 0000
William Annett OncoCyte Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

OncoCyte Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoCyte Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OncoCyte‘s full profile, request access.

Request a free trial

OncoCyte Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 02-Feb-2021 000000000000000000 0000 Laboratory Services (Healthcare) 000000 0000000
0000000 00000000 31-Jan-2020 000000000000000000 0000 Biotechnology 000000 000000 00
00000 00000000 05-Sep-2019 000000000 00000000 0000 Diagnostic Equipment 00000000 000000
Cell Targeting 28-Jan-2011 Merger/Acquisition 00.00 Biotechnology
To view OncoCyte’s complete investments and acquisitions history, request access »

OncoCyte Subsidiaries (1)

Company Name Industry Location Founded
0000000 00000000 Biotechnology Nashville, TN 0000
To view OncoCyte’s complete subsidiaries history, request access »